trending Market Intelligence /marketintelligence/en/news-insights/trending/Qcd7omv-wyRO4IcAT_idgQ2 content esgSubNav
In This List

Novartis Oncology CEO to retire

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Novartis Oncology CEO to retire

Novartis AG said Novartis Oncology CEO Bruno Strigini will retire for personal reasons.

He will step back from Novartis' executive committee by Dec. 31 and fully hand over in early 2018, the company said in a news release.

Strigini joined Novartis in 2014 as president of oncology and became CEO of the unit in July 2016. He previously served as Merck & Co. Inc.'s president for Europe and Canada.